Loading...
XNAS
MBAI
Market cap9mUSD
Dec 05, Last price  
1.66USD
1D
-4.97%
1Q
148.21%
Jan 2017
-99.71%
IPO
-99.88%
Name

Check Cap Ltd

Chart & Performance

D1W1MN
XNAS:MBAI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
95.86%
Rev. gr., 5y
%
Revenues
0k
00-788,000173,000244,0000000000
Net income
-18m
L-8.76%
-3,721,000-3,995,000-4,076,000-12,290,000-8,826,000-9,771,000-10,589,000-13,596,000-13,761,000-17,092,000-19,254,000-17,568,000
CFO
-17m
L-9.37%
-4,160,000-3,657,000-4,541,000-8,628,000-7,923,000-9,150,000-10,034,000-12,843,000-13,113,000-16,264,000-18,707,000-16,954,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
IPO date
Feb 19, 2015
Employees
85
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT